Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Acute effect of metformin on exercise capacity in active males

View through CrossRef
Aim:  Physical activity and metformin are often used concomitantly in the treatment of diabetes, even though little is known about possible interactions between these treatment modalities. This study was designed to examine the acute effect of metformin on oxygen consumption and lactate concentration during exercise.Methods:  Eleven healthy, active men [mean ± s.d.: age = 29.9 ± 3.7 years; body mass index = 25.2 ± 2.8 kg/m2; maximal oxygen consumption (VO2max) = 53.5 ± 8.9 ml/kg/min] completed a randomized, double‐blind, placebo‐controlled, crossover study. The testing protocol consisted of a standardized breakfast with metformin (1000 mg) or placebo. Three hours after breakfast, participants underwent a graded maximal exercise test on a cycle ergometer. Approximately 30 min after this exercise test, participants cycled continuously at an intensity below their ventilatory threshold for 45 min (mean exercise intensity = 69 ± 5.5% of VO2max).Results:  During the graded exercise test, average oxygen consumption was higher for the metformin condition (2.9 vs. 2.8 l/min, p = 0.04); however, there was no treatment effect on VO2max or ventilatory threshold. During continuous exercise, lactate was lower for the metformin condition (4.7 vs. 5.4 mmol/l, p = 0.05). Following a standardized lunch, glucose concentrations were lower in the metformin compared with the placebo condition (5.8 vs. 6.4 mmol/l, p = 0.04).Conclusion:  A single dose of metformin does not acutely influence maximal oxygen consumption or ventilatory threshold in healthy active males. The lower lactate concentration observed during continuous exercise with metformin was an unexpected finding considering that, in the resting state, metformin has been previously associated with a modest increase in lactate concentrations.
Title: Acute effect of metformin on exercise capacity in active males
Description:
Aim:  Physical activity and metformin are often used concomitantly in the treatment of diabetes, even though little is known about possible interactions between these treatment modalities.
This study was designed to examine the acute effect of metformin on oxygen consumption and lactate concentration during exercise.
Methods:  Eleven healthy, active men [mean ± s.
d.
: age = 29.
9 ± 3.
7 years; body mass index = 25.
2 ± 2.
8 kg/m2; maximal oxygen consumption (VO2max) = 53.
5 ± 8.
9 ml/kg/min] completed a randomized, double‐blind, placebo‐controlled, crossover study.
The testing protocol consisted of a standardized breakfast with metformin (1000 mg) or placebo.
Three hours after breakfast, participants underwent a graded maximal exercise test on a cycle ergometer.
Approximately 30 min after this exercise test, participants cycled continuously at an intensity below their ventilatory threshold for 45 min (mean exercise intensity = 69 ± 5.
5% of VO2max).
Results:  During the graded exercise test, average oxygen consumption was higher for the metformin condition (2.
9 vs.
2.
8 l/min, p = 0.
04); however, there was no treatment effect on VO2max or ventilatory threshold.
During continuous exercise, lactate was lower for the metformin condition (4.
7 vs.
5.
4 mmol/l, p = 0.
05).
Following a standardized lunch, glucose concentrations were lower in the metformin compared with the placebo condition (5.
8 vs.
6.
4 mmol/l, p = 0.
04).
Conclusion:  A single dose of metformin does not acutely influence maximal oxygen consumption or ventilatory threshold in healthy active males.
The lower lactate concentration observed during continuous exercise with metformin was an unexpected finding considering that, in the resting state, metformin has been previously associated with a modest increase in lactate concentrations.

Related Results

Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract Introduction and Objective. Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer age...
Metformin and Exercise in Type 2 Diabetes
Metformin and Exercise in Type 2 Diabetes
OBJECTIVE To determine the effect of metformin on the acute metabolic response to submaximal exercise, the effect of exercise on plasma metformin concentrations, ...
Metformin Inhibits Na+/H+ Exchanger NHE3 Resulting in Intestinal Water Loss
Metformin Inhibits Na+/H+ Exchanger NHE3 Resulting in Intestinal Water Loss
Glycemic control is the key to the management of type 2 diabetes. Metformin is an effective, widely used drug for controlling plasma glucose levels in diabetes, but it is often the...
Abstract 1682: Metformin synergistically enhances antitumor efficacy of sorafenib in vitro
Abstract 1682: Metformin synergistically enhances antitumor efficacy of sorafenib in vitro
Abstract Background: Previously, we observed anti-tumor effect of sorafenib in osteosarcoma cells. However, a number of studies suggested that cancer cells might esc...
Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal
Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal
<p dir="ltr">Objectives: This study aimed to evaluate lactic acidosis (LA) risk when using metformin combined with histamine H2 receptor inhibitors (H2RI) in patients with re...
Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal
Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal
<p dir="ltr">Objectives: This study aimed to evaluate lactic acidosis (LA) risk when using metformin combined with histamine H2 receptor inhibitors (H2RI) in patients with re...

Back to Top